These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3542053)

  • 1. Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complex.
    Abraham KI; Ieni JR; Meyerson LR
    Biochim Biophys Acta; 1987 Jan; 923(1):8-21. PubMed ID: 3542053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients.
    Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW
    J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p-Chloroamphetamine induces serotonin release through serotonin transporters.
    Rudnick G; Wall SC
    Biochemistry; 1992 Jul; 31(29):6710-8. PubMed ID: 1322169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]imipramine binding of protein nature in human platelets: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
    Marcusson J; Tiger G
    J Neurochem; 1988 Apr; 50(4):1032-6. PubMed ID: 3279163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between 3H-imipramine binding, 14C-serotonin uptake, and the surface area of blood platelets.
    Demet EM; Chicz-Demet A; Shaffer E; Ocariz J
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):289-96. PubMed ID: 2163060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Iodoimipramine, a novel ligand for the serotonin transporter.
    Humphreys CJ; Cassel D; Rudnick G
    Mol Pharmacol; 1989 Oct; 36(4):620-6. PubMed ID: 2811859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial serotonin transport into viable platelets and imipramine binding to platelet membranes.
    Rao ML; Frahnert C; Zagorski O
    J Neural Transm (Vienna); 2002 May; 109(5-6):547-56. PubMed ID: 12111448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport.
    Talvenheimo J; Nelson PJ; Rudnick G
    J Biol Chem; 1979 Jun; 254(11):4631-5. PubMed ID: 438209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-binding glycoprotein of rat platelets.
    Tamir H; Kupsky WJ; Huang YL; Gershon MD
    J Cell Sci; 1983 Jul; 62():439-58. PubMed ID: 6352718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet [3H]-imipramine binding by human plasma protein fractions.
    Strijewski A; Chudzik J; Tang SW
    Life Sci; 1988; 42(16):1543-50. PubMed ID: 3352466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubilization of the platelet plasma membrane serotonin transporter in an active form.
    Talvenheimo J; Rudnick G
    J Biol Chem; 1980 Sep; 255(18):8606-11. PubMed ID: 7410380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the platelet plasma-membrane 5-hydroxytryptamine transporter.
    Williams DC; Phillips OM
    Biochem Soc Trans; 1991 Feb; 19(1):112-4. PubMed ID: 2037132
    [No Abstract]   [Full Text] [Related]  

  • 13. 2-Nitroimipramine: a photoaffinity probe for the serotonin uptake/tricyclic binding site complex.
    Wennogle LP; Ashton RA; Schuster DI; Murphy RB; Meyerson LR
    EMBO J; 1985 Apr; 4(4):971-7. PubMed ID: 4018038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroimipramines - synthesis and pharmacological effects of potent long-acting inhibitors of [3H] serotonin uptake and [3H] imipramine binding.
    Rehavi M; Ittah Y; Skolnick P; Rice KC; Paul SM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):45-9. PubMed ID: 7121610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 16. Human platelet imipramine recognition sites: biochemical and pharmacological characterization.
    Wennogle LP; Beer B; Meyerson LR
    Pharmacol Biochem Behav; 1981 Dec; 15(6):975-82. PubMed ID: 7323121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serotonin transporter-imipramine "receptor".
    Talvenheimo J; Fishkes H; Nelson PJ; Rudnick G
    J Biol Chem; 1983 May; 258(10):6115-9. PubMed ID: 6853478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate and inhibitor binding and translocation by the platelet plasma membrane serotonin transporter.
    Humphreys CJ; Beidler D; Rudnick G
    Biochem Soc Trans; 1991 Feb; 19(1):95-8. PubMed ID: 2037207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium ion requirements for serotonin transport and imipramine binding.
    Rudnick G; Talvenheimo J; Fishkes H; Nelson PJ
    Psychopharmacol Bull; 1983; 19(3):545-9. PubMed ID: 6635128
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
    Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
    Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.